sesamol has been researched along with tyloxapol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, L; Guo, M; He, Y; Jiang, H; Liu, J; Ren, C; Shi, Y; Sun, M; Wang, B; Wang, W; Wang, X; Xie, Y; Xu, X | 1 |
1 other study(ies) available for sesamol and tyloxapol
Article | Year |
---|---|
The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Benzodioxoles; Clofibric Acid; Dose-Response Relationship, Drug; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Liver; Mice; Mice, Inbred Strains; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Phenols; Polyethylene Glycols; Protective Agents; Structure-Activity Relationship | 2021 |